Global Viral Disease Diagnosis Market
Global Viral Disease Diagnosis Market

Viral Disease Diagnosis Comprehensive Study by Diagnostic Test (Serodiagnostic Tests, Specimen Examination, Viral Isolation), Virus (Dengue virus, Hepatitis virus, HIV-1, Human Metapneumovirus, Measles Virus, Rabies virus, Avian Influenza, Enterovirus, Coronavirus, Poliovirus), End User (Hospitals, Physician, Clinics, Nursing homes, Commercial laboratories) Players and Region - Global Market Outlook to 2024

Viral Disease Diagnosis Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jun 2019 Edition 247 Pages 173 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
The tests used for diagnosing the different diseases such as dengue, hepatitis, HIV, measles, rabies, and others referred to viral disease diagnosis. Increasing number of patients with the above disease and rising prevalence of infection driving the demand for viral disease diagnosis market. Further, technological advancement in the molecular biology and rapid screening tests for infectious diseases propelling the market growth. In addition, rising healthcare infrastructure in the developing economies expected to drive the demand for viral disease diagnosis market over the forecasted period.

The market study is being classified and major geographies with country level break-up.

Danaher Corporation (United States), Thermo Fischer Scientific (United States), Becton Dickinson and Company (United States), Novartis (Switzerland), Abbott Laboratories (United States), Roche Holding AG (Switzerland), BioMerieux (France), Prescient Medicine Holdings LLC (United States) and Illumina, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Meridian Bioscience, Inc. (United States) and Qiagen NV (Germany).

Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Viral Disease Diagnosis market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Viral Disease Diagnosis market by Type, Application and Region.

On the basis of geography, the market of Viral Disease Diagnosis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Diagnostic Test, the sub-segment i.e. Serodiagnostic Tests will boost the Viral Disease Diagnosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Virus , the sub-segment i.e. Dengue virus will boost the Viral Disease Diagnosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Viral Disease Diagnosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growth in Clinical and Molecular Research Industry
  • Rise in the Prevalence of Viral Infections

Market Trend
  • Technological Developments in the Molecular Diagnostics Techniques

Restraints
  • Stringent Government Regulations Regarding Viral Disease Diagnosis
  • Lack of Skilled Professional for Clinical and Molecular Research

Opportunities
  • Emphasizing On Development of Specific Rapid Screening Tests for Different Viruses
  • Growing Healthcare Infrastructure in the Developing Economies

Challenges
  • Lack of Virological Laboratories in the Low and Middle Income Group Countries
  • Low Awareness about the Viral Disease Diagnosis Tests





Key Target Audience
Associations, Organizations, Forums, and Alliances, Government Bodies and Departments, Research Institutes, Business Consulting Firms and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Diagnostic Test
  • Serodiagnostic Tests
  • Specimen Examination
  • Viral Isolation

By Virus
  • Dengue virus
  • Hepatitis virus
  • HIV-1
  • Human Metapneumovirus
  • Measles Virus
  • Rabies virus
  • Avian Influenza
  • Enterovirus
  • Coronavirus
  • Poliovirus

By End User
  • Hospitals
  • Physician
  • Clinics
  • Nursing homes
  • Commercial laboratories

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Clinical and Molecular Research Industry
      • 3.2.2. Rise in the Prevalence of Viral Infections
    • 3.3. Market Challenges
      • 3.3.1. Lack of Virological Laboratories in the Low and Middle Income Group Countries
      • 3.3.2. Low Awareness about the Viral Disease Diagnosis Tests
    • 3.4. Market Trends
      • 3.4.1. Technological Developments in the Molecular Diagnostics Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Viral Disease Diagnosis, by Diagnostic Test, Virus , End User and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Viral Disease Diagnosis (Value)
      • 5.2.1. Global Viral Disease Diagnosis by: Diagnostic Test (Value)
        • 5.2.1.1. Serodiagnostic Tests
        • 5.2.1.2. Specimen Examination
        • 5.2.1.3. Viral Isolation
      • 5.2.2. Global Viral Disease Diagnosis by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Physician
        • 5.2.2.3. Clinics
        • 5.2.2.4. Nursing homes
        • 5.2.2.5. Commercial laboratories
      • 5.2.3. Global Viral Disease Diagnosis Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Viral Disease Diagnosis (Price)
  • 6. Viral Disease Diagnosis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fischer Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton Dickinson and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Roche Holding AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMerieux (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Prescient Medicine Holdings LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Illumina, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Viral Disease Diagnosis Sale, by Diagnostic Test, Virus , End User and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Viral Disease Diagnosis (Value)
      • 7.2.1. Global Viral Disease Diagnosis by: Diagnostic Test (Value)
        • 7.2.1.1. Serodiagnostic Tests
        • 7.2.1.2. Specimen Examination
        • 7.2.1.3. Viral Isolation
      • 7.2.2. Global Viral Disease Diagnosis by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Physician
        • 7.2.2.3. Clinics
        • 7.2.2.4. Nursing homes
        • 7.2.2.5. Commercial laboratories
      • 7.2.3. Global Viral Disease Diagnosis Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Viral Disease Diagnosis (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Viral Disease Diagnosis: by Diagnostic Test(USD Million)
  • Table 2. Viral Disease Diagnosis Serodiagnostic Tests , by Region USD Million (2013-2018)
  • Table 3. Viral Disease Diagnosis Specimen Examination , by Region USD Million (2013-2018)
  • Table 4. Viral Disease Diagnosis Viral Isolation , by Region USD Million (2013-2018)
  • Table 5. Viral Disease Diagnosis: by End User(USD Million)
  • Table 6. Viral Disease Diagnosis Hospitals , by Region USD Million (2013-2018)
  • Table 7. Viral Disease Diagnosis Physician , by Region USD Million (2013-2018)
  • Table 8. Viral Disease Diagnosis Clinics , by Region USD Million (2013-2018)
  • Table 9. Viral Disease Diagnosis Nursing homes , by Region USD Million (2013-2018)
  • Table 10. Viral Disease Diagnosis Commercial laboratories , by Region USD Million (2013-2018)
  • Table 11. South America Viral Disease Diagnosis, by Country USD Million (2013-2018)
  • Table 12. South America Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 13. South America Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 14. South America Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 15. Brazil Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 16. Brazil Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 17. Brazil Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 18. Argentina Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 19. Argentina Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 20. Argentina Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 21. Rest of South America Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 22. Rest of South America Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 23. Rest of South America Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 24. Asia Pacific Viral Disease Diagnosis, by Country USD Million (2013-2018)
  • Table 25. Asia Pacific Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 26. Asia Pacific Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 27. Asia Pacific Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 28. China Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 29. China Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 30. China Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 31. Japan Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 32. Japan Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 33. Japan Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 34. India Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 35. India Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 36. India Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 37. South Korea Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 38. South Korea Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 39. South Korea Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 40. Taiwan Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 41. Taiwan Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 42. Taiwan Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 43. Australia Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 44. Australia Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 45. Australia Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 46. Rest of Asia-Pacific Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 49. Europe Viral Disease Diagnosis, by Country USD Million (2013-2018)
  • Table 50. Europe Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 51. Europe Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 52. Europe Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 53. Germany Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 54. Germany Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 55. Germany Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 56. France Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 57. France Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 58. France Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 59. Italy Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 60. Italy Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 61. Italy Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 62. United Kingdom Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 63. United Kingdom Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 64. United Kingdom Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 65. Netherlands Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 66. Netherlands Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 67. Netherlands Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 68. Rest of Europe Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 69. Rest of Europe Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 70. Rest of Europe Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 71. MEA Viral Disease Diagnosis, by Country USD Million (2013-2018)
  • Table 72. MEA Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 73. MEA Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 74. MEA Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 75. Middle East Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 76. Middle East Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 77. Middle East Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 78. Africa Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 79. Africa Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 80. Africa Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 81. North America Viral Disease Diagnosis, by Country USD Million (2013-2018)
  • Table 82. North America Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 83. North America Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 84. North America Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 85. United States Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 86. United States Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 87. United States Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 88. Canada Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 89. Canada Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 90. Canada Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 91. Mexico Viral Disease Diagnosis, by Diagnostic Test USD Million (2013-2018)
  • Table 92. Mexico Viral Disease Diagnosis, by Virus USD Million (2013-2018)
  • Table 93. Mexico Viral Disease Diagnosis, by End User USD Million (2013-2018)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Viral Disease Diagnosis: by Diagnostic Test(USD Million)
  • Table 104. Viral Disease Diagnosis Serodiagnostic Tests , by Region USD Million (2019-2024)
  • Table 105. Viral Disease Diagnosis Specimen Examination , by Region USD Million (2019-2024)
  • Table 106. Viral Disease Diagnosis Viral Isolation , by Region USD Million (2019-2024)
  • Table 107. Viral Disease Diagnosis: by End User(USD Million)
  • Table 108. Viral Disease Diagnosis Hospitals , by Region USD Million (2019-2024)
  • Table 109. Viral Disease Diagnosis Physician , by Region USD Million (2019-2024)
  • Table 110. Viral Disease Diagnosis Clinics , by Region USD Million (2019-2024)
  • Table 111. Viral Disease Diagnosis Nursing homes , by Region USD Million (2019-2024)
  • Table 112. Viral Disease Diagnosis Commercial laboratories , by Region USD Million (2019-2024)
  • Table 113. South America Viral Disease Diagnosis, by Country USD Million (2019-2024)
  • Table 114. South America Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 115. South America Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 116. South America Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 117. Brazil Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 118. Brazil Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 119. Brazil Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 120. Argentina Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 121. Argentina Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 122. Argentina Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 123. Rest of South America Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 124. Rest of South America Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 125. Rest of South America Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 126. Asia Pacific Viral Disease Diagnosis, by Country USD Million (2019-2024)
  • Table 127. Asia Pacific Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 128. Asia Pacific Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 129. Asia Pacific Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 130. China Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 131. China Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 132. China Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 133. Japan Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 134. Japan Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 135. Japan Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 136. India Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 137. India Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 138. India Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 139. South Korea Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 140. South Korea Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 141. South Korea Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 142. Taiwan Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 143. Taiwan Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 144. Taiwan Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 145. Australia Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 146. Australia Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 147. Australia Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 148. Rest of Asia-Pacific Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 149. Rest of Asia-Pacific Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 150. Rest of Asia-Pacific Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 151. Europe Viral Disease Diagnosis, by Country USD Million (2019-2024)
  • Table 152. Europe Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 153. Europe Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 154. Europe Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 155. Germany Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 156. Germany Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 157. Germany Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 158. France Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 159. France Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 160. France Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 161. Italy Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 162. Italy Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 163. Italy Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 164. United Kingdom Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 165. United Kingdom Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 166. United Kingdom Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 167. Netherlands Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 168. Netherlands Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 169. Netherlands Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 170. Rest of Europe Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 171. Rest of Europe Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 172. Rest of Europe Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 173. MEA Viral Disease Diagnosis, by Country USD Million (2019-2024)
  • Table 174. MEA Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 175. MEA Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 176. MEA Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 177. Middle East Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 178. Middle East Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 179. Middle East Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 180. Africa Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 181. Africa Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 182. Africa Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 183. North America Viral Disease Diagnosis, by Country USD Million (2019-2024)
  • Table 184. North America Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 185. North America Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 186. North America Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 187. United States Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 188. United States Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 189. United States Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 190. Canada Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 191. Canada Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 192. Canada Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 193. Mexico Viral Disease Diagnosis, by Diagnostic Test USD Million (2019-2024)
  • Table 194. Mexico Viral Disease Diagnosis, by Virus USD Million (2019-2024)
  • Table 195. Mexico Viral Disease Diagnosis, by End User USD Million (2019-2024)
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Viral Disease Diagnosis: by Diagnostic Test USD Million (2013-2018)
  • Figure 5. Global Viral Disease Diagnosis: by End User USD Million (2013-2018)
  • Figure 6. South America Viral Disease Diagnosis Share (%), by Country
  • Figure 7. Asia Pacific Viral Disease Diagnosis Share (%), by Country
  • Figure 8. Europe Viral Disease Diagnosis Share (%), by Country
  • Figure 9. MEA Viral Disease Diagnosis Share (%), by Country
  • Figure 10. North America Viral Disease Diagnosis Share (%), by Country
  • Figure 11. Global Viral Disease Diagnosis share by Players 2018 (%)
  • Figure 12. Global Viral Disease Diagnosis share by Players (Top 3) 2018(%)
  • Figure 13. Global Viral Disease Diagnosis share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 17. Thermo Fischer Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fischer Scientific (United States) Revenue: by Geography 2018
  • Figure 19. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Becton Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 21. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Novartis (Switzerland) Revenue: by Geography 2018
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 25. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Roche Holding AG (Switzerland) Revenue: by Geography 2018
  • Figure 27. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 28. BioMerieux (France) Revenue: by Geography 2018
  • Figure 29. Prescient Medicine Holdings LLC (United States) Revenue, Net Income and Gross profit
  • Figure 30. Prescient Medicine Holdings LLC (United States) Revenue: by Geography 2018
  • Figure 31. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Illumina, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Global Viral Disease Diagnosis: by Diagnostic Test USD Million (2019-2024)
  • Figure 34. Global Viral Disease Diagnosis: by End User USD Million (2019-2024)
  • Figure 35. South America Viral Disease Diagnosis Share (%), by Country
  • Figure 36. Asia Pacific Viral Disease Diagnosis Share (%), by Country
  • Figure 37. Europe Viral Disease Diagnosis Share (%), by Country
  • Figure 38. MEA Viral Disease Diagnosis Share (%), by Country
  • Figure 39. North America Viral Disease Diagnosis Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Danaher Corporation (United States)
  • Thermo Fischer Scientific (United States)
  • Becton Dickinson and Company (United States)
  • Novartis (Switzerland)
  • Abbott Laboratories (United States)
  • Roche Holding AG (Switzerland)
  • BioMerieux (France)
  • Prescient Medicine Holdings LLC (United States)
  • Illumina, Inc. (United States)
Additional players considered in the study are as follows:
Meridian Bioscience, Inc. (United States) , Qiagen NV (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation